HPLC peptide purity: what the percentage actually measures
Purity by HPLC is an area-percent measurement, not a statement that a vial is 99% target compound by mass. The distinction changes how the number should be used at the bench.
- Last scientific review
- September 2026
- Published by
- Pure Helix
The separation
In reversed-phase HPLC, the sample is loaded onto a non-polar stationary phase — typically C18-bonded silica — and eluted with an increasing gradient of organic solvent, usually acetonitrile, against an aqueous phase containing an ion-pairing agent such as trifluoroacetic acid. Peptides partition between the two phases according to hydrophobicity, so species that differ by a single residue, a deamidation, or an oxidation often resolve into separate peaks.
A UV detector at 214 nm monitors the eluate. That wavelength is chosen because the peptide bond itself absorbs there, which makes the response broadly proportional across peptides rather than dependent on the presence of aromatic residues.
How the percentage is calculated
The chromatogram is integrated: the software computes the area under every resolved peak. Purity is reported as the area of the main peak divided by the total integrated area of all peaks, expressed as a percentage. A result of 99.7% area purity means that 99.7% of the UV-absorbing, column-eluting material detected in that run was the main peak.
Area percent is a ratio of detector response, not a ratio of mass. Two species with different UV responses at 214 nm do not contribute to the total in proportion to their weight.
What a 99% result does not establish
- It does not account for material that does not absorb at 214 nm — residual salts and many counter-ions are effectively invisible in this measurement.
- It does not account for material that never leaves the column, or that elutes in the void volume outside the integration window.
- It does not establish how much peptide is in the vial. Water content and counter-ion content can be substantial in a lyophilised product; quantitation is a separate measurement.
- It does not establish identity. An impurity co-eluting under the main peak is counted as main peak. Identity requires mass spectrometry.
- It does not establish sterility, endotoxin status, or biological activity.
Why methods must be stated alongside the number
Purity results are method-dependent. A shallower gradient resolves more closely-eluting related substances and typically lowers the reported purity of the same sample; a steep gradient can bury them under the main peak and raise it. Detection wavelength, column chemistry and integration thresholds all move the figure.
Comparing purity percentages across suppliers is therefore only meaningful when the method is disclosed. Pure Helix certificates state the method conditions alongside the result for exactly this reason.
Research use
Pure Helix supplies materials for laboratory research use only. Nothing on this page is medical advice, and none of the material described is for human or veterinary use.
Primary literature and standards
- ICH Q2(R2) — Validation of Analytical Procedures
- Mant CT, Hodges RS. Analysis of peptides by HPLC. Methods in Enzymology.Foundational treatment of reversed-phase separation behaviour in peptides.
Related reading
- Analytical TestingHow Pure Helix analytical testing worksEvery released lot carries an independent certificate of analysis. This page explains what is measured, how each result is produced, and — just as importantly — what each measurement does not establish.
- Analytical TestingLC-MS peptide identity: mass confirmation versus purityHPLC asks how much of the detected material is one species. Mass spectrometry asks whether that species is the molecule on the label. Neither substitutes for the other.
- Analytical TestingHow to read a peptide certificate of analysisA certificate is a record of one sample on one date by one method. Read in that order, it is informative; read as a badge, it is nearly meaningless.